Disrupting this complex regulation of IP3Rs by Bcl-2 and using IP3R-derived peptides could overcome apoptosis avoidance, one of the hallmarks of cancer [25, 26], and is, thus, of core interest for the development of novel anti-cancer strategies [27]. This evidence concerns the gene BCL2 and cancer.